Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
暂无分享,去创建一个
A. Ravaud | R. Motzer | M. Casey | A. Pantuck | H. Pandha | B. Escudier | D. George | J. Martini | M. Staehler | B. Laguerre | A. Magheli | Anup Patel | M. Lechuga | Sherry Li | P. Gerletti